Header cover image

Hong Kong (HSI) Life Sciences Industry Analysis

UpdatedApr 17, 2024
DataAggregated Company Financials
  • 7D-11.1%
  • 3M-48.2%
  • 1Y-70.1%
  • YTD-49.6%

Over the last 7 days, the Life Sciences industry has dropped 11%, driven by declines from every company within the industry. Overall the industry is down 70% in 12 months. Looking forward, earnings are forecast to grow by 39% annually.

Industry Valuation and Performance

Has the Hong Kong Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Apr 2024HK$108.5bHK$33.6bHK$3.1b33x35x3.2x
Fri, 15 Mar 2024HK$127.1bHK$33.3bHK$3.7b49.8x34.6x3.8x
Sun, 11 Feb 2024HK$124.0bHK$32.4bHK$3.0b46.5x41.4x3.8x
Tue, 09 Jan 2024HK$189.0bHK$32.3bHK$3.0b82.9x63.2x5.8x
Thu, 07 Dec 2023HK$216.4bHK$32.4bHK$3.0b84.1x72.3x6.7x
Sat, 04 Nov 2023HK$259.5bHK$30.1bHK$2.7b45.9x97.3x8.6x
Mon, 02 Oct 2023HK$245.6bHK$30.2bHK$2.7b43.6x91.8x8.1x
Wed, 30 Aug 2023HK$244.8bHK$30.4bHK$2.7b32.7x91.4x8.1x
Fri, 28 Jul 2023HK$229.2bHK$28.5bHK$2.8b24.1x83.3x8x
Sun, 25 Jun 2023HK$205.8bHK$28.5bHK$2.7b20x75.1x7.2x
Tue, 23 May 2023HK$228.3bHK$29.0bHK$2.8b22.1x80.6x7.9x
Thu, 20 Apr 2023HK$281.7bHK$29.5bHK$2.9b25.8x96x9.5x
Sat, 18 Mar 2023HK$252.9bHK$26.4bHK$2.1b23.6x122.8x9.6x
Mon, 13 Feb 2023HK$335.7bHK$26.6bHK$2.1b26.5x158.5x12.6x
Wed, 11 Jan 2023HK$349.6bHK$26.6bHK$2.1b27.2x164.3x13.2x
Fri, 09 Dec 2022HK$292.0bHK$25.9bHK$2.0b26.7x147.2x11.3x
Sun, 06 Nov 2022HK$237.0bHK$25.2bHK$1.8b23x132.8x9.4x
Tue, 04 Oct 2022HK$249.8bHK$25.7bHK$1.9b19.6x131.1x9.7x
Thu, 01 Sep 2022HK$361.2bHK$25.7bHK$2.4b28.1x153x14x
Sat, 30 Jul 2022HK$388.7bHK$22.3bHK$2.0b12x189.7x17.4x
Mon, 27 Jun 2022HK$400.1bHK$22.5bHK$2.1b16.4x191.6x17.8x
Wed, 25 May 2022HK$279.8bHK$22.6bHK$2.1b13.3x132.2x12.4x
Fri, 22 Apr 2022HK$292.6bHK$23.2bHK$2.3b14.1x127.7x12.6x
Sun, 20 Mar 2022HK$291.2bHK$18.7bHK$2.8b20.7x103.2x15.5x
Tue, 15 Feb 2022HK$303.8bHK$18.7bHK$2.8b25.7x108.1x16.3x
Thu, 13 Jan 2022HK$483.2bHK$18.6bHK$2.8b31.2x172.8x25.9x
Sat, 11 Dec 2021HK$540.4bHK$18.6bHK$2.8b37.2x193.4x29x
Mon, 08 Nov 2021HK$524.2bHK$18.6bHK$2.8b35.5x188.1x28.3x
Wed, 06 Oct 2021HK$598.1bHK$18.5bHK$2.8b48.6x216.9x32.4x
Fri, 03 Sep 2021HK$605.6bHK$18.4bHK$2.7b49.7x220.7x32.9x
Sun, 01 Aug 2021HK$610.8bHK$18.4bHK$2.7b53.8x222.6x33.2x
Wed, 05 May 2021HK$524.9bHK$15.7bHK$1.4b47.5x363.3x33.5x
Price to Earnings Ratio


Total Market Cap: HK$524.9bTotal Earnings: HK$1.4bTotal Revenue: HK$15.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Life Sciences Industry Price to Earnings3Y Average 147.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 35.0x which is lower than its 3-year average PE of 148x.
  • The 3-year average PS ratio of 16.0x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 29% per year over the last three years.
  • Revenues for these companies have grown 29% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market-1.93%
Life Sciences-11.15%
Clinical Research and Equipment-11.15%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.